EGFR and breast carcinoma: The anti-invasive effect of oxidized streptolysin O on MDA-MB231 breast cancer cells is characterized by its ability to activate the autophosphorylation of EGFR selectively on tyrosine residues besides Y845, indicating that, in this case, Y845 may not be involved in the anti-cancer malignancy [93].